CONSTITUENT REPORT
citronellal
Citronellal is a lemon-scented monoterpene aldehyde that defines the character of citronella, lemon eucalyptus, and makrut-leaf style oils in the AromaForge archive. Compared with many aroma constituents, citronellal has a moderate direct research footprint: identity and occurrence are strong, fragrance-safety review coverage exists, and several rodent and in-vitro papers report anti-inflammatory, antinociceptive, and redox-related effects. The evidence is still preclinical, so the best archive description is that citronellal is a well-established scent marker with animal and cell-study activity signals, not a confirmed human therapeutic active.
Chemical identity and composition
PubChem lists citronellal as C10H18O with IUPAC name 3,7-dimethyloct-6-enal. In essential oils it is especially associated with citronella grass and Corymbia citriodora / lemon eucalyptus chemotypes, where it can dominate the volatile profile.
Aroma and practical use
- Use the recorded lemony, fresh, sweet, citronella-like, green, citrus descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2013 Pharm Biol mouse study found that citronellal at 25-100 mg/kg inhibited carrageenan-, TNF-alpha-, PGE2-, and dopamine-induced mechanical nociception, with pathway testing implicating NO-cGMP-ATP-sensitive K+ signaling.
This is a constituent-level paper with better-than-minimal mechanistic interpretation, although it remains a rodent pain model rather than human outcome evidence.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2011 Biological Research full-text paper reported that intraperitoneal citronellal reduced carrageenan-induced leukocyte migration, inhibited carrageenan- and arachidonic-acid-induced paw edema, and lowered lipid and protein oxidation markers in rats.
Because the article is openly readable, it provides stronger detail than the abstract-only papers and supports both anti-inflammatory and redox-protective topic language.
This experimental finding does not establish benefit, dose or safety in people using this blend.
The 2011 full-text paper suggested that citronellal's edema-lowering effect may be associated with inhibition within the arachidonic-acid pathway and reduced reactive oxygen species burden in tissues.
This is best treated as an author interpretation from preclinical work rather than as a settled biochemical fact.
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedCitronellal has a modern RIFM fragrance ingredient safety assessment, but this pass did not extract a directly quoted constituent-specific public dermal threshold from that review.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
As an aldehydic fragrance constituent found in several leave-on materials, citronellal is better treated as a potential sensitization-management concern than as an unrestricted topical active.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
The positive activity literature for citronellal is preclinical and dose-dependent, so it should not be translated into medical claims for inhalation or skin use.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
citralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citral report →GeraniolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Geraniol report →CitronellolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Citronellol report →NeralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Neral report →geranialAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read geranial report →LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalool report →How the effects were investigated
no_cgmp_atp_sensitive_potassium_channel_pathway
A mouse Pharm Biol paper reported that citronellal's antinociceptive effect was reversed by L-NAME and glibenclamide in the PGE2 model, supporting involvement of the NO-cGMP-ATP-sensitive K+ channel pathway.
This experimental finding does not establish benefit, dose or safety in people using this blend.
possible_arachidonic_acid_pathway_and_lipoxygenase_interference
A full-text SciELO study interpreted citronellal's effects on carrageenan- and arachidonic-acid-induced edema as consistent with interference in arachidonic acid mediator production, especially a lipoxygenase-linked component.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- This pass did not verify strong isolated human clinical literature for citronellal.
- A directly readable public dermal limit specific to isolated citronellal was not confirmed in the reviewed sources.
- Most benefit-oriented claims in the accessible literature are from rodent models, not human aroma-use studies.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.